rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Rafael A. Rodriguez

Director

Company insider

Files Form 4 as: Director, Neogen.

In numbers

Trades disclosed
23
Buys
1
Sells
0
Bought
$34K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
7 Oct 2021
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NEOG NeogenDirector · Diagnostics & Labs · last 1 Oct 20261 buy · 0 sells

Activity over time

1 Apr 2025 – 1 Oct 2026
01Apr 25Sep 25Jan 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$120K9,804 at $12.24filing
1 Oct 2026filed 2 Oct 2026NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—20,558 at $0.00filing
27 Oct 2025filed 28 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$11K1,777 at $6.19filing
27 Oct 2025filed 28 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$11K1,777 at $6.19filing
23 Oct 2025filed 27 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—50,814 at $0.00filing
23 Oct 2025filed 27 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$120K19,769 at $6.07filing
7 Oct 2025filed 9 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$12K2,071 at $5.63filing
7 Oct 2025filed 9 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$12K2,071 at $5.63filing
22 Apr 2025filed 22 Apr 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Bought$34K7,474 at $4.59filing
28 Oct 2024filed 29 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$25K1,776 at $13.81filing
28 Oct 2024filed 29 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$25K1,776 at $13.81filing
24 Oct 2024filed 28 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—18,653 at $0.00filing
24 Oct 2024filed 28 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$82K6,075 at $13.58filing
7 Oct 2024filed 9 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$31K2,070 at $15.07filing
7 Oct 2024filed 9 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$3,514236 at $14.89filing
7 Oct 2024filed 9 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$31K2,070 at $15.07filing
7 Oct 2024filed 9 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$3,514236 at $14.89filing
26 Oct 2023filed 31 Oct 2023NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,716 at $0.00filing
26 Oct 2023filed 31 Oct 2023NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—5,329 at $0.00filing
6 Oct 2022filed 11 Oct 2022NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—18,416 at $0.00filing

News

Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)NEOG · themarketsdaily.com · 18 Oct 2026

0 headlines in the last 90 days name Rafael A. Rodriguez; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Mikheal NassifCEO · CEO at Neogen, filing Form 4 there in the last year
Jeffrey D. CapelloDirector · Director at Neogen, filing Form 4 there in the last year
James C. BorelDirector · Director at Neogen, filing Form 4 there in the last year
Avi PelossofDirector · Director at Neogen, filing Form 4 there in the last year
Catherine E. WotekiDirector · Director at Neogen, filing Form 4 there in the last year